AwardTape · Defense awards · Medical · Drugs and biologicals · W81K0025CA008
W81K0025CA008: $1.2M definitive contract to Abbott Molecular Inc
Abbott Molecular Inc holds a definitive contract from Department of the Army with $1.2M obligated since Oct 2023 and $1.2M obligated over its life, against a ceiling of $5.8M. Latest action May 28, 2026.
For molecular transplant, respiratory, and sexual health testing department of pathology and area laboratory services
| PIID | W81K0025CA008 |
|---|---|
| Type | definitive contract |
| Company | Abbott Molecular Inc |
| Agency | Department of the Army |
| Contracting office | W40M MRC0 WEST |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING |
| Obligated since Oct 2023 | $1.2M |
| Total obligated (lifetime) | $1.2M |
| Ceiling (base and all options) | $5.8M |
| Base date | Jun 27, 2025 |
| Latest action | May 28, 2026 |
| End date | Sep 30, 2029 |
| Actions since Oct 2023 | 4 |
| Pricing | Firm fixed price |
| Competition | Competed under simplified acquisition |
| Place of performance | TX |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial